181 related articles for article (PubMed ID: 31919194)
1. ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma.
Beasley R; Braithwaite I; Semprini A; Kearns C; Weatherall M; Harrison TW; Papi A; Pavord ID
Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31919194
[No Abstract] [Full Text] [Related]
2. ICS/formoterol maintenance and reliever therapy: how far beyond asthma?
Beasley R; Bruce P; Hatter L
Thorax; 2023 May; 78(5):430-431. PubMed ID: 36863775
[No Abstract] [Full Text] [Related]
3. Budesonide-formoterol reliever therapy in intermittent
Papi A; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Holliday M; Houghton C; Morandi L; Oldfield K; Pavord ID; Reddel HK; Williams M; Weatherall M; Beasley R;
Eur Respir J; 2021 Feb; 57(2):. PubMed ID: 33060151
[No Abstract] [Full Text] [Related]
4. Beclometasone dipropionate/formoterol maintenance and reliever therapy asthma exacerbation benefit increases with blood eosinophil level.
Brusselle G; Nicolini G; Santoro L; Guastalla D; Papi A
Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33737409
[No Abstract] [Full Text] [Related]
5. The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review.
Beasley R; Bruce P; Houghton C; Hatter L
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):762-772.e1. PubMed ID: 36639054
[TBL] [Abstract][Full Text] [Related]
6. Satisfaction with single maintenance and reliever therapy or as-needed combined inhaled corticosteroid-formoterol in adults with asthma.
LaCava AF; Gleeson PK; Apter AJ
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):952-954.e1. PubMed ID: 36470520
[No Abstract] [Full Text] [Related]
7. A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma.
Krings JG; Gerald JK; Blake KV; Krishnan JA; Reddel HK; Bacharier LB; Dixon AE; Sumino K; Gerald LB; Brownson RC; Persell SD; Clemens CJ; Hiller KM; Castro M; Martinez FD
Am J Respir Crit Care Med; 2023 Feb; 207(4):390-405. PubMed ID: 36538711
[No Abstract] [Full Text] [Related]
8. Insights from the AUSTRI study on reliever use before and after asthma exacerbations.
Busse W; Stempel D; Aggarwal B; Boucot I; Forth R; Raphiou I; Rabe KF; Reddel HK
J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1916-1918.e2. PubMed ID: 35413473
[No Abstract] [Full Text] [Related]
9. Budesonide/formoterol as maintenance and reliever therapy compared to fixed-budesonide/formoterol plus albuterol reliever for pediatric asthma: A cost-utility analysis in Colombia.
Rodríguez-Martínez CE; Sossa-Briceño MP; Nino G
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3816-3818.e2. PubMed ID: 34102348
[No Abstract] [Full Text] [Related]
10. The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today.
Krings JG; Beasley R
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):870-879. PubMed ID: 38237858
[TBL] [Abstract][Full Text] [Related]
11. The evidence base for ICS/formoterol maintenance and reliever therapy in severe asthma.
Beasley R; Noble J; Weatherall M
Eur Respir J; 2024 Jun; 63(6):. PubMed ID: 38901890
[TBL] [Abstract][Full Text] [Related]
12. Implementing Antiinflammatory Reliever Strategies in Asthma: The Evolving Paradigm of Asthma Management.
Zaeh SE; Eakin MN; Chupp G
Chest; 2024 Feb; 165(2):250-252. PubMed ID: 38336438
[No Abstract] [Full Text] [Related]
13. The management of mild asthma.
O'Byrne PM; Reddel HK; Beasley R
Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33093120
[TBL] [Abstract][Full Text] [Related]
14. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
15. Trends in prescribing as-needed inhaled corticosteroid (ICS)-Formoterol for patients with asthma.
Li J; Price KR; Weeda ER; Garner SS
Respir Med; 2023 Feb; 207():107096. PubMed ID: 36574912
[No Abstract] [Full Text] [Related]
16. What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever?
Jenkins CR; Bateman ED; Sears MR; O'Byrne PM
Respirology; 2020 Aug; 25(8):804-815. PubMed ID: 32237004
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility of as-needed combination low-dose budesonide-formoterol in adolescents mild asthma.
Buendía JA; Guerrero Patiño D; Talamoni HL
Pediatr Pulmonol; 2021 Dec; 56(12):3699-3705. PubMed ID: 34473917
[TBL] [Abstract][Full Text] [Related]
18. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
Aalbers R; Vogelmeier C; Kuna P
Respir Med; 2016 Feb; 111():1-7. PubMed ID: 26614594
[TBL] [Abstract][Full Text] [Related]
19. A simple and effective evidence-based approach to asthma management: ICS-formoterol reliever therapy.
Levy ML; Beasley R; Bostock B; Capstick TG; Crooks MG; Fleming L; Freeman D; Marsh V; Rupani H; Whittamore A; Barnes PJ; Bush A
Br J Gen Pract; 2024 Feb; 74(739):86-89. PubMed ID: 38272684
[No Abstract] [Full Text] [Related]
20. The low hanging fruit of anti-inflammatory reliever therapy.
Beasley R
Respirology; 2024 Mar; 29(3):256-257. PubMed ID: 38135280
[No Abstract] [Full Text] [Related]
[Next] [New Search]
